Shares in the San Francisco-based company closed at $37.56 each on Thursday in New York, versus the IPO price of $32 apiece.
The level at the close gives Hinge Health a market value of about $2.9 billion based on the outstanding shares listed in its filings, not including preferred stock that could convert to common shares. It has a fully diluted value of about $3.4 billion when ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
